Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial).

Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial).

<h4>Background</h4>Research priorities in Antimicrobial Stewardship (AMS) have rapidly evolved in the last decade. The need for a more efficient use of antimicrobials have fueled plenty of studies to define the optimal duration for antibiotic treatments, and yet, there still are large ar...

Full description

Bibliographic Details
Main Authors: José Molina, Clara María Rosso-Fernández, Enrique Montero-Mateos, José Ramón Paño-Pardo, María Solla, Ana Belén Guisado-Gil, Rocío Álvarez-Marín, María Eugenia Pachón-Ibáñez, Adelina Gimeno, Guillermo Martín-Gutiérrez, José Antonio Lepe, José Miguel Cisneros, SHORTEN-2 trial team
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0277333

Internet

https://doi.org/10.1371/journal.pone.0277333

Similar Items